[HTML][HTML] Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence

SZ Alshawwa, AA Kassem, RM Farid, SK Mostafa… - Pharmaceutics, 2022 - mdpi.com
There has been an increasing demand for the development of nanocarriers targeting
multiple diseases with a broad range of properties. Due to their tiny size, giant surface area …

Controlled release and targeted drug delivery with poly (lactic-co-glycolic acid) nanoparticles: reviewing two decades of research

A Zeb, M Gul, TTL Nguyen, HJ Maeng - Journal of Pharmaceutical …, 2022 - Springer
Background Controlled release and targeted delivery of the drug payload are the two most
fascinating applications of nanoparticle-based systems explored in the recent past. The …

Cilostazol-loaded solid lipid nanoparticles: Bioavailability and safety evaluation in an animal model

M Bibi, F ud Din, Y Anwar, NA Alkenani, AT Zari… - Journal of Drug Delivery …, 2022 - Elsevier
Cilostazol (CLZ) is an antiplatelet agent with limited solubility (∼ 6 μg/ml at 25° C), poor
absorption and low oral bioavailability. In this study, solid lipid nanoparticles (SLNs) were …

A detailed insight of the tumor targeting using nanocarrier drug delivery system

S Batool, S Sohail, F ud Din, AH Alamri… - Drug Delivery, 2023 - Taylor & Francis
Human struggle against the deadly disease conditions is continued since ages. The
contribution of science and technology in fighting against these diseases cannot be ignored …

Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses

S Batool, F Zahid, F Ud-Din, SS Naz… - Drug development …, 2021 - Taylor & Francis
Objective The purpose of this study was to develop novel carbopol-based miltefosine-
loaded transfersomal gel (HePCTG) for the treatment of cutaneous leishmaniasis (CL) via …

[PDF][PDF] RETRACTED ARTICLE: Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

G Yu, Z Ali, A Sajjad Khan, K Ullah… - International Journal …, 2021 - Taylor & Francis
Yu G, Ali Z, Sajjad Khan A, et al. Int J Nanomedicine. 2021; 16: 3255-3273. At the authors
request, the Editor and Publisher of International Journal of Nanomedicine wish to retract the …

Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat …

S Rubab, K Naeem, I Rana, N Khan, M Afridi… - International Journal of …, 2021 - Elsevier
The present study aims to develop curcumin-loaded nanostructured lipid carriers (CUR-
NLCs) and investigate their neuroprotective effects in lipopolysaccharide (LPS)-induced …

Controlled therapeutic delivery of CO from carbon monoxide-releasing molecules (CORMs)

HI Choi, A Zeb, MS Kim, I Rana, N Khan… - Journal of Controlled …, 2022 - Elsevier
Carbon monoxide (CO) has been regarded as a “silent killer” for its toxicity toward biological
systems. However, a low concentration of endogenously produced CO has shown a number …

[HTML][HTML] Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight

H Jamshaid, FU Din, GM Khan - Journal of Nanobiotechnology, 2021 - Springer
As a neglected tropical disease, Leishmaniasis is significantly instigating morbidity and
mortality across the globe. Its clinical spectrum varies from ulcerative cutaneous lesions to …

Statistical optimization of co-loaded rifampicin and pentamidine polymeric nanoparticles for the treatment of cutaneous leishmaniasis

MM Khan, SS Zaidi, FJ Siyal, SU Khan, G Ishrat… - Journal of Drug Delivery …, 2023 - Elsevier
Topical drug delivery against cutaneous leishmaniasis (CL) serves as an effective alternate
approach to improve efficacy and reduce systemic adverse effects. The purpose of this study …